Medical Equipment

An Important Factor Driving the Epigenetics Diagnostics Market Is the Growing Demand For Personalized Medicine Fueling The Growth Of The Market Due To Advancements In Genetic And Molecular Profiling

March 12, 2026March 12, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Epigenetics Diagnostics Market Over The Period 2026–2030?

The epigenetics diagnostics market has experienced rapid growth in recent years. This market is projected to expand from $16.56 billion in 2025 to $19.29 billion by 2026, registering a compound annual growth rate (CAGR) of 16.5%. The expansion witnessed during the historic period can be attributed to factors such as the limited availability of epigenetic diagnostic tools, a reliance on conventional molecular biology methods, increasing awareness of epigenetic research, a rise in academic and clinical research activities, and the slow adoption of automated instrumentation.

The epigenetics diagnostics market is poised for significant expansion in the coming years. Projections indicate it will reach $35.17 billion by 2030, exhibiting a robust compound annual growth rate (CAGR) of 16.2%. This anticipated growth during the forecast period can be attributed to several factors, including ongoing technological progress in sequencing and epigenetic analysis, increasing investments in personalized medicine, the broadening scope of diagnostics for oncology and metabolic diseases, the incorporation of cloud-based bioinformatics services, and a rising demand from pharmaceutical and biotechnology companies. Key trends expected over this period include a greater embrace of epigenetic biomarker kits, increased utilization of next-generation sequencing and microarray systems, the growth of data analysis and bioinformatics services, an intensified focus on applications in oncology and personalized medicine, and the integration of automated liquid handling along with high-throughput platforms.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27286&type=smp

Which Major Factors Are Driving The Expansion Of The Epigenetics Diagnostics Market?

The increasing requirement for personalized medicine is anticipated to fuel the expansion of the epigenetics diagnostics market moving forward. Personalized medicine is a methodology that customizes medical treatment considering an individual’s genetic makeup, biology, and lifestyle elements. The rising demand for personalized medicine is a result of advancements in genetic and molecular profiling, which facilitate treatments precisely adapted to a person’s unique biological composition, thereby enhancing effectiveness and minimizing side effects. Epigenetics diagnostics contributes to personalized medicine by identifying distinct epigenetic patterns that inform tailored prevention and treatment plans, leading to optimal patient outcomes. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, stated that the FDA granted approval to 16 novel personalized therapies for patients with rare diseases in 2023, a significant rise from six in 2022. Thus, the escalating demand for personalized medicine is a key factor propelling the growth of the epigenetics diagnostics market.

How Is The Epigenetics Diagnostics Market Divided Into Its Major Segments?

The epigenetics diagnostics market covered in this report is segmented –

1) By Product: Kits And Reagents, Software And Services, Instruments

2) By Technology: Deoxyribonucleic Acid (DNA) Methylation, Histone Methylation, Histone Acetylation, Large NonCoding, Ribonucleic Acid (RNA), Micro Ribonucleic Acid (RNA) Modification, Chromatin Structures

3) By Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications

4) By End User: Pharmaceutical And Biotechnology firms, Academic And Research Institutes, Clinical Diagnostic Laboratories

Subsegments:

1) By Kits and Reagents: Deoxyribonucleic Acid Methylation Kits, Histone Modification Kits, Chromatin Accessibility Kits, Bisulfite Conversion Kits, Polymerase Chain Reaction Reagents, Antibodies and Probes, Enzymes and Buffers

2) By Software and Services: Data Analysis Software, Bioinformatics Services, Epigenetic Data Interpretation, Cloud-based Data Storage, Custom Assay Development, Validation and Consulting Services

3) By Instruments: Next-Generation Sequencers, Microarray Systems, Polymerase Chain Reaction and Quantitative Polymerase Chain Reaction Instruments, Mass Spectrometry Systems, Imaging Systems, Automation and Liquid Handling Systems

How Are Trends Transforming The Epigenetics Diagnostics Market Landscape?

Key companies in the epigenetics diagnostics industry are prioritizing the development of innovative strategies, like clinical-grade epigenetic analysis, to improve the precision, responsiveness, and clinical utility in identifying epigenetic changes associated with diseases. Clinical-grade epigenetic analysis refers to utilizing validated and standardized methodologies for detecting epigenetic alterations with the exactness and dependability required for clinical diagnoses and treatment planning. For example, in October 2024, EpiMedTech, a biotechnology company based in Singapore, launched epiGeneComplete. This clinical-grade test integrates genetic and epigenetic assessments through next-generation sequencing and advanced DNA methylation techniques to deliver comprehensive insights into vital health indicators, including aging, stress, inflammation, addiction risk, and metabolism. Administered in CAP-accredited laboratories, this non-invasive, saliva-based test offers high sensitivity and accuracy, supports tailored health profiling, and is designed as an open, adaptable platform for future diagnostic expansion, marking a significant advancement in routine health screening and early disease detection.

Who Are The Prominent Organizations Shaping The Epigenetics Diagnostics Market?

Major companies operating in the epigenetics diagnostics market are F. Hoffmann-La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., GeneTex Inc., Bio-Techne Corporation, Promega Corporation, New England Biolabs Incorporated, Pacific Biosciences of California Inc., Enzo Biochem Inc., Diagenode Société Anonyme, Zymo Research Corporation, Active Motif Inc., ADmit Therapeutics SL, Epigentek Group Inc., INHERENT Biosciences Inc.

Read the full epigenetics diagnostics market report here:

https://www.thebusinessresearchcompany.com/report/epigenetics-diagnostics-global-market-report

Which Region Currently Holds The Largest Share Of The Epigenetics Diagnostics Market?

North America was the largest region in the epigenetics diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the epigenetics diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Epigenetics Diagnostics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27286&type=smp

Browse Through More Reports Similar to the Global Epigenetics Diagnostics Market 2026, By The Business Research Company

Microfinance Market Report 2026

https://www.thebusinessresearchcompany.com/report/microfinance-global-market-report

Cloud Based Financial Platform Market Report 2026

https://www.thebusinessresearchcompany.com/report/cloud-based-financial-platform-global-market-report

Investments Market Report 2026

https://www.thebusinessresearchcompany.com/report/investments-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795